Jane H. Hollingsworth, Director at Diffusion Pharmaceuticals Inc. (DFFN), bought 32,786 shares at $0.61 ($20K) on 2021-05-13, disclosed to the SEC on 2021-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.